Drug Pipeline Sustainability

What does the Drug development industry have in common with every other major industry sector?  When it comes to product development, on the surface, very little!  Nostrapharmus explores this in more detail. 

In 2006, nearly 500 products were launched every day across all other sectors, that's a 50% increase from 2005 and almost 100% from 2004, yet in that same period the combined might of the Pharmaceutical industry, the greatest R&D force both by numbers and dollars spent, launched just 21 active substances.  Nostrapharmus notes that what makes this picture even bleaker, is the fact that spend on R&D has increased annually without fail, yet launched half the active ingredients.  The spending increase is inexorably up, the rate of new releases declining.

So, is the industry failing to innovate, are there structural impediments in the industry that are driving down the rate of innovation, or has the industry simply run out of good ideas?

If you would like to read the article in full, please click on the pdf link below:

Drug Pipeline Sustainability

or to view the magazine follow the link below, the article can be found on page 58

http://viewer.zmags.com/publication/9978d7ea#/9978d7ea/58

About Pharma magazine
Aimed at the international pharmaceutical and bio-pharmaceutical community, Pharma magazine covers every aspect of manufacturing from R&D to finished product. With a worldwide circulation of more than 40,000 individuals it is the first truly global magazine for the pharma industry, bringing together the disciplines of discovery and development, the drug manufacturing process and the resultant business and management issues.

For further information visit the Pharma magazine website www.pharma-mag.com